Amarantus Bioscience Holdings Inc (AMBS)

[macnqueso]

Real deal on dilution...

Dilution is always a risk with developmental phase biotechs... and no investor likes dilution, but there is a worse scenario than dilution and that is if the company has no money to move the science forward...

I am optimistic that AMBS will be able to find alternative ways to fund the science... but if they do need some reasonable dilution along the way I will be ok with it and utilize it as a buying opportunity when share price inevitably dips...

The key for me is always the science and the ability of management to move the science forward toward monetization... as long as that is happening... I know my investment will be just fine...